Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

References

• Dapper H, Oechsner M, Münch S, et al. Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer. Strahlenther Onkol. 2020;196(4):368–375. doi: 10.1007/s00066-020-01587-y.
   PubMed Web of Science ®Google Scholar
• Johnson N, Pellino G, Simillis C, et al. Discrepancies between NCCN and ESMO guidelines in the management of anal cancer: a qualitative review. Updates Surg. 2017;69(3):345–349. doi: 10.1007/s13304-017-0470-8.
   PubMed Web of Science ®Google Scholar
• Rao S, Guren MG, Khan K, et al. Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(9):1087–1100. doi: 10.1016/j.annonc.2021.06.015.
   PubMed Web of Science ®Google Scholar
• Rouard N, Peiffert D, Rio E, et al. Intensity-modulated radiation therapy of anal squamous cell carcinoma: relationship between delineation quality and regional recurrence. Radiother Oncol. 2019;131:93–100. doi: 10.1016/j.radonc.2018.10.021.
   PubMed Web of Science ®Google Scholar
• Bentzen AG, Guren MG, Vonen B, et al. Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort. Radiother Oncol. 2013;108(1):55–60. doi: 10.1016/j.radonc.2013.05.037.
   PubMed Web of Science ®Google Scholar
• Sterner A, Derwinger K, Staff C, et al. Quality of life in patients treated for anal carcinoma-a systematic literature review. Int J Colorectal Dis. 2019;34(9):1517–1528. doi: 10.1007/s00384-019-03342-x.
   PubMed Web of Science ®Google Scholar
• Kachnic LA, Winter KA, Myerson RJ, et al. Long-term outcomes of NRG oncology/RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-Fluorouracil and mitomycin-C for the reduction of acute morbidity in anal canal cancer. Int J Radiat Oncol Biol Phys. 2022;112(1):146–157. doi: 10.1016/j.ijrobp.2021.08.008.
   PubMed Web of Science ®Google Scholar
• Kachnic LA, Winter K, Myerson RJ, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86(1):27–33. doi: 10.1016/j.ijrobp.2012.09.023.
   PubMed Web of Science ®Google Scholar
• UK guidelines for IMRT in anal cancer. [Dec 17, 2019]. Available from: http://analimrtguidance.co.uk/national-anal-imrt-guidance-v3.pdf.
   Google Scholar
• Damico N, Meyer J, Das P, et al. ECOG-ACRIN guideline for contouring and treatment of early stage anal cancer using IMRT/IGRT. Pract Radiat Oncol. 2022;12(4):335–347. doi: 10.1016/j.prro.2022.01.015.
   PubMed Web of Science ®Google Scholar
• Myerson RJ, Garofalo MC, El Naqa I, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74(3):824–830. doi: 10.1016/j.ijrobp.2008.08.070.
   PubMed Web of Science ®Google Scholar
• Ng M, Leong T, Chander S, et al. Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys. 2012;83(5):1455–1462. doi: 10.1016/j.ijrobp.2011.12.058.
   PubMed Web of Science ®Google Scholar
• Dahl O, Myklebust MP, Dale JE, et al. Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version. Acta Oncol. 2020;59(9):1016–1023. doi: 10.1080/0284186X.2020.1778180.
   PubMed Web of Science ®Google Scholar
• Leon O, Guren MG, Radu C, et al. Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer. Eur J Cancer. 2015;51(18):2740–2746. doi: 10.1016/j.ejca.2015.08.029.
   PubMed Web of Science ®Google Scholar
• Blinde SE, Schasfoort R, Mens JW, et al. Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma. Dis Colon Rectum. 2014;57(5):578–584. doi: 10.1097/DCR.0000000000000050.
   PubMed Web of Science ®Google Scholar
• Joo JH, Park JH, Yoon SM, et al. Long-term oncologic and complication outcomes in anal cancer patients treated with radiation therapy. J Cancer Res Ther. 2020;16(Supplement):S194–s200. doi: 10.4103/jcrt.JCRT_34_18.
   PubMed Web of Science ®Google Scholar
• Ortholan C, Resbeut M, Hannoun-Levi JM, et al. Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 study). Int J Radiat Oncol Biol Phys. 2012 ;82(5):1988–1995. doi: 10.1016/j.ijrobp.2011.02.010.
   PubMed Web of Science ®Google Scholar
• Thompson SR, Lee ISY, Carroll S, et al. Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated? ANZ J Surg. 2018;88(9):870–875. doi: 10.1111/ans.14398.
   PubMed Web of Science ®Google Scholar
• Zilli T, Betz M, Bieri S, et al. Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control. Int J Radiat Oncol Biol Phys. 2013;87(1):60–66. doi: 10.1016/j.ijrobp.2013.03.008.
   PubMed Web of Science ®Google Scholar
• Bentzen AG, Guren MG, Wanderas EH, et al. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort. Int J Radiat Oncol Biol Phys. 2012 ;83(2):e173-80–e180. doi: 10.1016/j.ijrobp.2011.12.062.
   PubMed Web of Science ®Google Scholar
• Slørdahl KS, Klotz D, Olsen J, et al. Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer. Acta Oncol. 2021;60(7):921–930. doi: 10.1080/0284186X.2021.1918763.
   PubMed Web of Science ®Google Scholar
• Wright JL, Patil SM, Temple LK, et al. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. Int J Radiat Oncol Biol Phys. 2010;78(4):1064–1072. doi: 10.1016/j.ijrobp.2009.09.029.
   PubMed Web of Science ®Google Scholar
• Lengelé B, Scalliet P. Anatomical bases for the radiological delineation of lymph node areas. Part III: pelvis and lower limbs. Radiother Oncol. 2009;92(1):22–33. doi: 10.1016/j.radonc.2008.11.007.
   PubMed Web of Science ®Google Scholar
• Frennered A, Scherman J, Buchwald P, et al. Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes. BMC Cancer. 2021;21(1):447. doi: 10.1186/s12885-021-08187-8.
   PubMed Web of Science ®Google Scholar
• Shakir R, Adams R, Cooper R, et al. Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2020;106(2):329–339. doi: 10.1016/j.ijrobp.2019.10.016.
   PubMed Web of Science ®Google Scholar
• Dapper H, Schiller K, Münch S, et al. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines. BMC Cancer. 2019;19(1):742. doi: 10.1186/s12885-019-5970-0.
   PubMed Web of Science ®Google Scholar
• Dapper H, Habl G, Hirche C, et al. Dosimetric quantification of the incidental irradiation of the 'true’ (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines. Acta Oncol. 2018;57(6):825–830. doi: 10.1080/0284186X.2017.1415459.
   PubMed Web of Science ®Google Scholar
• Nilsson MP, Nilsson ED, Johnsson A, et al. Patterns of recurrence in anal cancer: a detailed analysis. Radiat Oncol. 2020;15(1):125. doi: 10.1186/s13014-020-01567-7.
   PubMed Web of Science ®Google Scholar
• Das P, Bhatia S, Eng C, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007;68(3):794–800. doi: 10.1016/j.ijrobp.2006.12.052.
   PubMed Web of Science ®Google Scholar
• Tomaszewski JM, Link E, Leong T, et al. Twenty-five-year experience with radical chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2012;83(2):552–558. doi: 10.1016/j.ijrobp.2011.07.007.
   PubMed Web of Science ®Google Scholar
• Gerum S, Iglseder W, Schmid R, et al. Practice of radiation therapy for anal cancer in Austria-a survey on behalf of the Austrian radiation oncology society gastrointestinal tumor group (ÖGRO-GIT). Strahlenther Onkol. 2021;197(11):953–961. doi: 10.1007/s00066-021-01842-w.
   PubMed Web of Science ®Google Scholar
• Holliday EB, Lester SC, Harmsen WS, et al. Extended-field chemoradiation therapy for definitive treatment of anal canal squamous cell carcinoma involving the para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2018;102(1):102–108. doi: 10.1016/j.ijrobp.2018.04.076.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhou Y, Wang D, et al. Prophylactic extended-field irradiation in patients with cervical cancer: a literature review. Front Oncol. 2020;10:579410. doi: 10.3389/fonc.2020.579410.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Chun J, Kim TH, et al. Patterns of locoregional recurrence after radical cystectomy for stage T3-4 bladder cancer: a radiation oncologist’s point of view. Yonsei Med J. 2021;62(7):569–576. doi: 10.3349/ymj.2021.62.7.569.
   PubMed Web of Science ®Google Scholar
• Peters M, de Leeuw AAC, Nomden CN, et al. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: an EMBRACE analysis. Radiother Oncol. 2021;163:150–158. doi: 10.1016/j.radonc.2021.08.020.
   PubMed Web of Science ®Google Scholar
• Spratt DE, Vargas HA, Zumsteg ZS, et al. Patterns of lymph node failure after dose-escalated radiotherapy: implications for extended pelvic lymph node coverage. Eur Urol. 2017;71(1):37–43. doi: 10.1016/j.eururo.2016.07.043.
   PubMed Web of Science ®Google Scholar
• de Meric de Bellefon M, Lemanski C, Castan F, et al. Long-term follow-up experience in anal canal cancer treated with intensity-modulated radiation therapy: clinical outcomes, patterns of relapse and predictors of failure. Radiother Oncol. 2020;144:141–147. doi: 10.1016/j.radonc.2019.11.016.
   PubMed Web of Science ®Google Scholar
• Sia J, Mou W, Agas RA, et al. Long-term patterns of failure and the value of blood prognostic markers in anal cancers treated with intensity-modulated radiation therapy. Clin Colorectal Cancer. 2022;21(2):e102–e112.
   PubMed Web of Science ®Google Scholar
• Hodges JC, Das P, Eng C, et al. Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement. Int J Radiat Oncol Biol Phys. 2009;75(3):791–794. doi: 10.1016/j.ijrobp.2008.11.021.
   PubMed Web of Science ®Google Scholar
• Wind KL, Serup-Hansen E, Havelund BM, et al. Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases - a report from the Danish anal cancer group. Acta Oncol. 2022;61(3):321–327. doi: 10.1080/0284186X.2021.1999497.
   PubMed Web of Science ®Google Scholar
• Vilarino-Varela MJ, Taylor A, Rockall AG, et al. A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging. Radiother Oncol. 2008;89(2):192–196. doi: 10.1016/j.radonc.2008.07.023.
   PubMed Web of Science ®Google Scholar
• Garda AE, Navin PJ, Merrell KW, et al. Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation. Radiother Oncol. 2020;149:128–133. doi: 10.1016/j.radonc.2020.05.018.
   PubMed Web of Science ®Google Scholar
• Fontanilla HP, Klopp AH, Lindberg ME, et al. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol. 2013;3(1):45–53. doi: 10.1016/j.prro.2012.02.003.
   PubMedGoogle Scholar
• Wang D, Wang W, Liu X, et al. A modified delineation method of para-aortic nodal clinical target volume in patients with locally advanced cervical cancer. Cancer Med. 2022;11(1):28–39. doi: 10.1002/cam4.4418.
   PubMed Web of Science ®Google Scholar
• Small W, Jr., Bosch WR, Harkenrider MM, et al. NRG oncology/RTOG consensus guidelines for delineation of clinical target volume for intensity modulated pelvic radiation therapy in postoperative treatment of endometrial and cervical cancer: an update. Int J Radiat Oncol Biol Phys. 2021;109(2):413–424. doi: 10.1016/j.ijrobp.2020.08.061.
   PubMed Web of Science ®Google Scholar